إعلان
إعلان
LEGN
Legend Biotech Corporation - ADR
21.51
USDبرعاية
-0.23
-1.07%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
21.57
+0.07
+0.31%
تقارير أرباح LEGN
النسبة الإيجابية المفاجئة
LEGN تفوق 9 من 20 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$321.79M
/-$0.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+18.16%
/-63.64%
التغير الضمني من Q4 24 (Revenue/ EPS)
+72.52%
/-153.33%
Legend Biotech Corporation - ADR earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, LEGN reported earnings of -0.22 USD per share (EPS) for Q3 25, missing the estimate of -0.08 USD, resulting in a -155.52% surprise. Revenue reached 272.33 مليون, compared to an expected 277.95 مليون, with a -2.02% difference. The market reacted with a -2.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 321.79 مليون USD, implying an decrease of -63.64% EPS, and increase of 18.16% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Legend Biotech Corporation - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Legend Biotech Corporation - ADR reported EPS of -$0.22, missing estimates by -155.52%, and revenue of $272.33M, -2.02% below expectations.
How did the market react to Legend Biotech Corporation - ADR's Q3 2025 earnings?
The stock price moved down -2.67%, changed from $32.03 before the earnings release to $31.18 the day after.
When is Legend Biotech Corporation - ADR expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Legend Biotech Corporation - ADR's next earnings report?
Based on 18
analysts, Legend Biotech Corporation - ADR is expected to report EPS of -$0.08 and revenue of $321.79M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان